Appili Therapeutics Says FDA Approves LIKMEZ Metronidazole Oral Suspension

RTTNews | Pred 681 dňami
Appili Therapeutics Says FDA Approves LIKMEZ Metronidazole Oral Suspension

(RTTNews) - Biopharmaceutical company Appili Therapeutics, Inc. (APLI.TO, APLIF.PK) announced Monday that its manufacturing and commercialization partner, Saptalis Pharmaceuticals, LLC received approval from the U.S. Food and Drug Administration (FDA) for Metronidazole Oral Suspension 500mg/5mL (ATI-1501).

ATI-1501, Appili's liquid oral reformulation of the antibiotic metronidazole, has been licensed to Saptalis for commercialization in the U.S., and other selected territories. The FDA also approved LIKMEZ as the brand name for ATI-1501.

Metronidazole is a widely used frontline oral treatment with over 10 million prescriptions written in the U.S. every year to help treat parasitic and anaerobic bacterial infections.

The current tablet form of metronidazole is the only other approved oral form on the U.S. market.

Appili expects to receive milestone payments and royalties from Saptalis based on this FDA approval and Saptalis' commercialization plans.

read more
European Economic News Preview: BoE Likely To Cut Rates

European Economic News Preview: BoE Likely To Cut Rates

The Bank of England is widely expected to cut its interest rates for the fifth time in a year to support the economy even as inflation continued to stay stubbornly above the target. Markets anticipate a quarter-point cut, bringing the bank rate to 4.00 percent, which will be the lowest since early 2023.
RTTNews | Pred 12 minútami
European Shares Poised For Mixed Open

European Shares Poised For Mixed Open

European stocks are seen opening on a mixed note Thursday after U.S. President Donald Trump announced he will impose a 100 percent tariff on imports of semiconductors and chips, with exemptions for companies relocating production to the U.S.
RTTNews | Pred 37 minútami
Sensex, Nifty Open Lower On Tariff Concerns

Sensex, Nifty Open Lower On Tariff Concerns

Indian shares opened a tad lower on Thursday after U.S. President Donald Trump signed an executive order imposing an additional 25 percent tariff on India as a "penalty" in response to its continued purchase of Russian oil.
RTTNews | Pred 1 h 45 min
Australian Market Extends Early Losses In Mid-market

Australian Market Extends Early Losses In Mid-market

The Australian market is extending early losses in mid-market moves on Thursday, snapping a three session winning streak, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,850 level, with weakness in iron ore miners and energy stocks.
RTTNews | Pred 2 h 41 min
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian stock markets are trading mostly higher on Thursday, despite the broadly positive cues from Wall Street overnight, after U.S. President Donald Trump said the U.S. was closing in on the trade deal with China. Traders also remain optimistic about the US Fed cutting interest rates as early as September based on the recent economic data from the U.S.
RTTNews | Pred 3 h 9 min
Thai Stock Market May See Continued Support On Thursday

Thai Stock Market May See Continued Support On Thursday

The Thai stock market has moved higher in three straight sessions, gathering more than 45 points or 3.9 percent along the way. The Stock Exchange of Thailand now sits just beneath the 1,265-point plateau and it's expected to extend its gains again on Thursday.
RTTNews | Pred 4 h 12 min